Robert A Lippe - Net Worth and Insider Trading
Robert A Lippe Net Worth
The estimated net worth of Robert A Lippe is at least $2 Million dollars as of 2024-07-16. Robert A Lippe is the COO of Liquidia Corp and owns about 193,788 shares of Liquidia Corp (LQDA) stock worth over $2 Million. Details can be seen in Robert A Lippe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert A Lippe has not made any transactions after 2023-11-30 and currently still holds the listed stock(s).
Transaction Summary of Robert A Lippe
Robert A Lippe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert A Lippe owns 2 companies in total, including Liquidia Corp (LQDA) , and Alexza Pharmaceuticals Inc (ALXA) .
Click here to see the complete history of Robert A Lippe’s form 4 insider trades.
Insider Ownership Summary of Robert A Lippe
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
LQDA | Liquidia Corp | 2023-11-30 | Chief Operations Officer |
ALXA | Alexza Pharmaceuticals Inc | 2015-06-12 | EVP & Operations & COO |
Robert A Lippe Latest Holdings Summary
Robert A Lippe currently owns a total of 1 stock. Robert A Lippe owns 193,788 shares of Liquidia Corp (LQDA) as of November 30, 2023, with a value of $2 Million.
Latest Holdings of Robert A Lippe
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LQDA | Liquidia Corp | 2023-11-30 | 193,788 | 12.83 | 2,486,300 |
Holding Weightings of Robert A Lippe
Robert A Lippe Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert A Lippe has made a total of 5 transactions in Liquidia Corp (LQDA) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Liquidia Corp is the sale of 497 shares on November 30, 2023, which brought Robert A Lippe around $3,618.
Insider Trading History of Robert A Lippe
- 1
Robert A Lippe Trading Performance
GuruFocus tracks the stock performance after each of Robert A Lippe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert A Lippe is -7.97%. GuruFocus also compares Robert A Lippe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert A Lippe within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert A Lippe's insider trading performs compared to the benchmark.
Performance of Robert A Lippe
Robert A Lippe Ownership Network
Ownership Network List of Robert A Lippe
Ownership Network Relation of Robert A Lippe
Robert A Lippe Owned Company Details
What does Liquidia Corp do?
Who are the key executives at Liquidia Corp?
Robert A Lippe is the Chief Operations Officer of Liquidia Corp. Other key executives at Liquidia Corp include Chief Medical Officer Rajeev Saggar , SVP & Commercial Scott Moomaw , and Chief Financial Officer Michael Kaseta .
Liquidia Corp (LQDA) Insider Trades Summary
Over the past 18 months, Robert A Lippe made 4 insider transaction in Liquidia Corp (LQDA) with a net sale of 3,632. Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 16,385 shares made by Scott Moomaw , a net sale of 8,951 shares made by Jason Adair , and a net sale of 27,061 shares made by Rajeev Saggar .
In summary, during the past 3 months, insiders sold 22,542 shares of Liquidia Corp (LQDA) in total and bought 0 shares, with a net sale of 22,542 shares. During the past 18 months, 134,735 shares of Liquidia Corp (LQDA) were sold and 1,536,313 shares were bought by its insiders, resulting in a net purchase of 1,401,578 shares.
Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Liquidia Corp Insider Transactions
Robert A Lippe Mailing Address
Above is the net worth, insider trading, and ownership report for Robert A Lippe. You might contact Robert A Lippe via mailing address: C/o Alexza Pharmaceuticals, Inc., 2091 Stierlin Court, Mountain View Ca 94043.